MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

Pfizer

Cerrado

SectorSalud

22.97 0.75

Resumen

Variación precio

24h

Actual

Mínimo

22.5

Máximo

23.09

Métricas clave

By Trading Economics

Ingresos

-4.1B

411M

Ventas

63M

18B

P/B

Media del Sector

15.631

57.333

BPA

0.63

Rentabilidad por dividendo

7.8

Margen de beneficio

2.314

Empleados

81,000

EBITDA

-4.3B

2.5B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+22.04% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

7.80%

2.63%

Próximas Ganancias

29 abr 2025

Fecha Próximo Dividendo

13 jun 2025

Próxima Fecha de Ex Dividendo

9 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-26B

126B

Apertura anterior

22.22

Cierre anterior

22.97

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Pfizer Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

14 abr 2025, 11:09 UTC

Principales Movimientos del Mercado

Pfizer Shares Slip After Company Scraps Weight-Loss Pill

9 abr 2025, 18:18 UTC

Principales Movimientos del Mercado

Pharma Shares Reverse Losses After Tariff Pause

9 abr 2025, 09:39 UTC

Principales Movimientos del Mercado

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

19 mar 2025, 07:34 UTC

Adquisiciones, fusiones, absorciones

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 mar 2025, 17:26 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Dispose of Remaining Shareholding in Haleon

14 abr 2025, 14:36 UTC

Principales Noticias

Pfizer Halts Development of Weight-Loss Pill -- Update

14 abr 2025, 14:14 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Viking Seen as Potential Ticket To Get Pfizer Back Into Obesity Game -- Market Talk

14 abr 2025, 10:45 UTC

Principales Noticias

Pfizer Halts Development of Weight-Loss Pill -- WSJ

8 abr 2025, 21:26 UTC

Ganancias

Pfizer Stock's Fall to '97 Level Lifts Yield Near 8%. Dividend Looks Safe. -- Barrons.com

26 mar 2025, 22:29 UTC

Principales Noticias

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26 mar 2025, 19:19 UTC

Principales Noticias

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26 mar 2025, 17:39 UTC

Principales Noticias

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

18 mar 2025, 16:58 UTC

Adquisiciones, fusiones, absorciones

Haleon Intends to Cancel Purchased Ordinary Shares

18 mar 2025, 16:57 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 mar 2025, 16:56 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 mar 2025, 16:56 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 mar 2025, 16:52 UTC

Adquisiciones, fusiones, absorciones

Haleon Takes Note of Announcement

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: This Is Subject to Customary Closing Conditions

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Bookbuilding Period Will Commence Immediately

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18 mar 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

18 mar 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

18 mar 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

Citigroup: This Represents Approx 7.3% Stake in Haleon

18 mar 2025, 16:46 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

17 mar 2025, 09:00 UTC

Principales Noticias

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

28 feb 2025, 12:00 UTC

Principales Noticias

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

14 feb 2025, 11:38 UTC

Principales Noticias
Ganancias

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

Comparación entre iguales

Cambio de precio

Pfizer Esperado

Precio Objetivo

By TipRanks

22.04% repunte

Estimación a 12 meses

Media 27.8 USD  22.04%

Máximo 32 USD

Mínimo 23 USD

De acuerdo con 17 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

17 ratings

5

Comprar

12

Mantener

0

Vender

Puntuación técnica

By Trading Central

22.12 / 23.055Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Very Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.